Hoth Therapeutics Files 8-K: Administrative Update, Nasdaq Listing Confirmed

Ticker: HOTH · Form: 8-K · Filed: 2024-01-09T00:00:00.000Z

Sentiment: neutral

Topics: administrative, exchange-listing, corporate-governance

TL;DR

**Hoth Therapeutics filed an administrative 8-K, confirming its Nasdaq listing; no new material news.**

AI Summary

Hoth Therapeutics, Inc. filed an 8-K on January 9, 2024, reporting an 'Other Event' that occurred on January 8, 2024. This filing primarily serves to update administrative information, such as confirming its common stock trades under the symbol HOTH on The Nasdaq Stock Market LLC. For investors, this filing is largely administrative and does not contain new financial or operational news that would significantly impact the stock's value, but it confirms the company's continued listing on a major exchange.

Why It Matters

This filing is mainly administrative, confirming Hoth Therapeutics' listing on Nasdaq, which is important for liquidity and investor confidence, but it doesn't contain new material financial or operational news.

Risk Assessment

Risk Level: low — This 8-K filing is purely administrative and does not introduce any new financial or operational risks to the company.

Analyst Insight

A smart investor would note this administrative filing confirms Hoth Therapeutics' continued listing on Nasdaq, which is a standard operational detail, but would not expect any immediate stock price movement based solely on this non-material update.

Key Players & Entities

FAQ

What was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on January 8, 2024.

What is the trading symbol for Hoth Therapeutics, Inc. common stock?

The trading symbol for Hoth Therapeutics, Inc. common stock is HOTH.

On which exchange is Hoth Therapeutics, Inc. common stock registered?

Hoth Therapeutics, Inc. common stock is registered on The Nasdaq Stock Market LLC.

What is the par value of Hoth Therapeutics, Inc. common stock?

The par value of Hoth Therapeutics, Inc. common stock is $0.0001.

What is the primary purpose of this 8-K filing by Hoth Therapeutics, Inc.?

The primary purpose of this 8-K filing, under 'Other Events,' is to provide an administrative update, including confirming its common stock's registration on The Nasdaq Stock Market LLC under the trading symbol HOTH.

From the Filing

0001213900-24-002248.txt : 20240109 0001213900-24-002248.hdr.sgml : 20240109 20240109150320 ACCESSION NUMBER: 0001213900-24-002248 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240108 ITEM INFORMATION: Other Events FILED AS OF DATE: 20240109 DATE AS OF CHANGE: 20240109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hoth Therapeutics, Inc. CENTRAL INDEX KEY: 0001711786 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821553794 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38803 FILM NUMBER: 24523007 BUSINESS ADDRESS: STREET 1: 1 ROCKEFELLER PLAZA, SUITE 1039 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 551-578-2261 MAIL ADDRESS: STREET 1: 1 ROCKEFELLER PLAZA, SUITE 1039 CITY: NEW YORK STATE: NY ZIP: 10020 8-K 1 ea191413-8k_hoththera.htm CURRENT REPORT false 0001711786 0001711786 2024-01-08 2024-01-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported) January 8, 2024   Hoth Therapeutics, Inc. (Exact name of registrant as specified in its charter)   Nevada   001-38803   82-1553794 (State or other jurisdiction of incorporation)   (Commission File Number)   (I. R. S. Employer Identification No.)   1 Rockefeller Plaza , Suite 1039 New York , New York 10020 (Address of principal executive offices, including ZIP code)   ( 646 ) 756-2997 (Registrant’s telephone number, including area code)   Not Applicable (Former name or former address, if changed since last report)    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))    Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common stock, $0.0001 par value   HOTH   The Nasdaq  Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☒   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 8.01 Other Events.   On January 8, 2024 Hoth Therapeutics filed a patent application with the U.S. Patent and Trademark Office (“USPTO”) for the use of a therapeutic for weight loss (obesity) and the side effects associated with certain weight loss (obesity) therapeutics.   Obesity is a disorder characterized by the accumulation of excess fat in the body. Obesity has been recognized as one of the leading causes of disease and is emerging as a global problem. Various methods of treating obesity and related conditions, involve administering certain med

View on Read The Filing